Armstrong Pharms patents expiration
1. Primatene Mist patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8367734 | ARMSTRONG PHARMS | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
Jan, 2026
(1 year, 8 months from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Nov 07, 2021 |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 07 November, 2018
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
More Information on Dosage
PRIMATENE MIST family patents
